(Q45734909)

English

Discontinuation of Pneumocystis carinii prophylaxis in patients infected with human immunodeficiency virus: a meta-analysis and decision analysis

scientific article published on 22 October 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

0 references

Discontinuation of Pneumocystis carinii prophylaxis in patients infected with human immunodeficiency virus: a meta-analysis and decision analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

decision analysis

1 reference

based on heuristic

inferred from title

Pneumocystis carinii

object named as

Pneumocystis carinii

1 reference

based on heuristic

inferred from title

2

object named as

Ioannidis JP

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

Trikalinos TA

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

0 references

publication date

22 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1901-1909

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Recovery of the immune system with antiretroviral therapy: the end of opportunism?

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV outpatient study (HOPS).

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Haemophilus influenzae pneumonia in human immunodeficiency virus-infected patients. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Pneumonia in HIV-infected patients: a case-control survey of factors involved in risk and prevention

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Prophylaxis for opportunistic infections in an era of effective antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Discontinuation of Secondary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis againstPneumocystis cariniiPneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe

1 reference

https://api.crossref.org/works/10.1086%2F323198

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45734909&oldid=2079080630"